share_log

CVS Health | 4: Statement of changes in beneficial ownership of securities-Director Finucane Anne A.

SEC ·  Dec 10 05:42

Summary by Futu AI

On 12/05/2024, Anne A. Finucane, a director at CVS Health, made a bona fide gift of 2,665 shares of common stock. The transaction was executed at a price of $56.86 per share, with a total market value of $151,531.90.Following the transaction, Finucane directly owns 4,567.2482 shares of CVS Health common stock. Additionally, she indirectly holds 25,198 shares through the Finucane Family Trust. The indirect ownership remains unchanged after this transaction.This stock disposition was reported as completed, with no acquisitions recorded in the same filing. The gifting of shares by company insiders can sometimes be part of estate planning or philanthropic efforts, though the specific reason for this gift was not disclosed in the filing.
On 12/05/2024, Anne A. Finucane, a director at CVS Health, made a bona fide gift of 2,665 shares of common stock. The transaction was executed at a price of $56.86 per share, with a total market value of $151,531.90.Following the transaction, Finucane directly owns 4,567.2482 shares of CVS Health common stock. Additionally, she indirectly holds 25,198 shares through the Finucane Family Trust. The indirect ownership remains unchanged after this transaction.This stock disposition was reported as completed, with no acquisitions recorded in the same filing. The gifting of shares by company insiders can sometimes be part of estate planning or philanthropic efforts, though the specific reason for this gift was not disclosed in the filing.

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.